Eiger BioPharmaceuticals, Inc. Profile Avatar - Palmy Investing

Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is …

Biotechnology
US, Palo Alto [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Eiger BioPharmaceuticals, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Eiger BioPharmaceuticals, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Eiger BioPharmaceuticals, Inc..

End of EIGR's Analysis
CIK: 1305253 CUSIP: 28249U105 ISIN: US28249U2042 LEI: - UEI: -
Secondary Listings
EIGR has no secondary listings inside our databases.